We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Protein That Causes Damage in Early Brain Development Linked to Schizophrenia

By LabMedica International staff writers
Posted on 01 Dec 2014
Print article
Image: Structure of a typical neuron dendrite (Photo courtesy of Wikimedia Commons).
Image: Structure of a typical neuron dendrite (Photo courtesy of Wikimedia Commons).
Overexpression of a protein encoded by a susceptibility gene for schizophrenia was found to cause defective cortical patterning, which results in pathological structural changes in the developing brain.

The role of nitric oxide synthase 1 adaptor protein (NOS1AP) in the development of schizophrenia was studied in a rat model by investigators at Rutgers University (New Brunswick, NJ, USA). NOS1AP is cytosolic protein that binds to the signaling molecule, neuronal nitric oxide synthase (nNOS). This protein has a C-terminal PDZ-binding domain that mediates interactions with nNOS and an N-terminal phosphotyrosine binding (PTB) domain that binds to the small monomeric G protein, Dexras1. Studies have shown that this protein functions as an adapter protein linking nNOS to specific targets, such as Dexras1 and the synapsins.

Working with a rat model, the investigators knocked down or co-overexpressed NOS1AP and a GFP (green fluorescent protein) or TagRFP (red fluorescent protein) reporter in neuronal progenitor cells of the embryonic rat neocortex using an utero electroporation technique. They analyzed sections of cortex (ventricular zone, intermediate zone, and cortical plate containing GFP or TagRFP positive cells and counted the percentage of positive cells that migrated to each region from at least three rats for each condition.

Results published in the October 29, 2014, online edition of the journal Biological Psychiatry revealed that NOS1AP overexpression disrupted neuronal migration, resulting in increased cells in the intermediate zone and fewer cells in the cortical plate. An overabundance of NOS1AP also inhibited the process of dendritogenesis, neuronal growth during early brain development that is crucial to creating appropriate neural network structures necessary for all brain functions. In contrast, results from rats where NOS1AP production was "knocked down" showed increased neuronal migration, with more cells reaching the cortical plate.

"When the brain develops, it sets up a system of the right type of connectivity to make sure that communication can occur," said senior author Dr. Bonnie Firestein, professor of cell biology and neuroscience at Rutgers University. "What we saw here was that the nerve cells did not move to the correct locations and did not have dendrites that branch out to make the connections that were needed. The next step would be to let the disease develop in the laboratory and try to treat the over expression of the protein with an antipsychotic therapy to see if it works."

Related Links:

Rutgers University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.